2-214728537-CTTTTTT-CTTTT
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BS1BS2
The ENST00000471590.5(BARD1):n.806_807delAA variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00683 in 582,996 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00025 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0090 ( 0 hom. )
Consequence
BARD1
ENST00000471590.5 non_coding_transcript_exon
ENST00000471590.5 non_coding_transcript_exon
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.392
Publications
1 publications found
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- familial ovarian cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00025 (36/143986) while in subpopulation AFR AF = 0.000659 (26/39446). AF 95% confidence interval is 0.000461. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 36 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 36AN: 143960Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
36
AN:
143960
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00898 AC: 3944AN: 439010Hom.: 0 AF XY: 0.00886 AC XY: 2015AN XY: 227520 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
3944
AN:
439010
Hom.:
AF XY:
AC XY:
2015
AN XY:
227520
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
212
AN:
11802
American (AMR)
AF:
AC:
175
AN:
14718
Ashkenazi Jewish (ASJ)
AF:
AC:
77
AN:
12218
East Asian (EAS)
AF:
AC:
116
AN:
26746
South Asian (SAS)
AF:
AC:
282
AN:
33272
European-Finnish (FIN)
AF:
AC:
143
AN:
24174
Middle Eastern (MID)
AF:
AC:
30
AN:
2290
European-Non Finnish (NFE)
AF:
AC:
2695
AN:
289812
Other (OTH)
AF:
AC:
214
AN:
23978
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.284
Heterozygous variant carriers
0
329
659
988
1318
1647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000250 AC: 36AN: 143986Hom.: 0 Cov.: 0 AF XY: 0.000215 AC XY: 15AN XY: 69636 show subpopulations
GnomAD4 genome
AF:
AC:
36
AN:
143986
Hom.:
Cov.:
0
AF XY:
AC XY:
15
AN XY:
69636
show subpopulations
African (AFR)
AF:
AC:
26
AN:
39446
American (AMR)
AF:
AC:
1
AN:
14562
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3420
East Asian (EAS)
AF:
AC:
0
AN:
4986
South Asian (SAS)
AF:
AC:
0
AN:
4570
European-Finnish (FIN)
AF:
AC:
1
AN:
7676
Middle Eastern (MID)
AF:
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
AC:
6
AN:
66158
Other (OTH)
AF:
AC:
1
AN:
1980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.